Find a Tender Service

NHS National Generic Pharmaceuticals Wave 13

The NHS Commissioning Board (operating under the name of NHS England)

Awarded

goods

Framework agreement

3 lots

Price only

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from The NHS Commissioning Board (operating under the name of NHS England), and hundreds more across the UK public sector.

Key details

Contracting authority

The NHS Commissioning Board (operating under the name of NHS England)

central gov

Region

Runcorn

Delivery: United Kingdom

Sector

Healthcare & Medical

Contract value

Not stated by buyer

Submissions closed

Not stated by buyer

Published

14 January 2022

Procurement

Procedure type

Open procedure

CPV classifications

33600000 Pharmaceutical products

What happened

Description

Potential periods of call-offs under the framework agreement:

Transition (Everolimus) CESW: 1 March 2022 – 30 September 2023 (19 months) LSNE: 1 March 2022 – 31 January 2023 (11 months) NWLN: 1 March 2022 – 31 January 2023 (11 months)

Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months)

Hospital Only Products CESW: 1 February 2022 – 30 September 2023 (20 months) LSNE: 1 February 2022 – 31 May 2024 (28 months) NWLN: 1 February 2022 – 31 January 2023 (12 months)

Full description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

Transition (Everolimus) CESW: 1 March 2022 – 30 September 2023 (19 months) LSNE: 1 March 2022 – 31 January 2023 (11 months) NWLN: 1 March 2022 – 31 January 2023 (11 months)

Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months)

Hospital Only Products CESW: 1 February 2022 – 30 September 2023 (20 months) LSNE: 1 February 2022 – 31 May 2024 (28 months) NWLN: 1 February 2022 – 31 January 2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Awarded suppliers (131)

Suppliers

Martindale Pharma
Sandoz Ltd
Teva UK Limited
Dr.Reddy's Laboratories (UK) Limited
Accord-UK Ltd
Pfizer Ltd
Allergan
Medreich PLC
ennogen healthcare ltd
GlaxoSmithKline UK Limited
Syri Limited (T/A Thame Laboratories)
medac Pharma LLP
Rosemont Pharmaceuticals Limited
Mercury Pharmaceuticals Limited
Selective Supplies Ltd.
Consilient Health Ltd
Glenmark Pharmaceuticals Europe Limited
Healthcare Pharma Ltd
Thornton and Ross Ltd
Mylan
Macleods Pharma UK Limited
Wockhardt UK Limited
Dr Falk Pharma UK Ltd
Desitin Pharma Ltd
Torrent Pharma UK Ltd
Fontus Health Ltd
Aspire Pharma Limited
Amarox Limited
AOP Orphan Ltd
Ranbaxy UK
Arcadia Pharma Ltd T/A Arcadia Medical
Derma UK
Zista Pharma Ltd
Aspen Pharmacare UK Limited
Manx Healthcare Ltd
Colonis Pharma Ltd
Roche Products Ltd
Profile Pharma Ltd
Zentiva Pharma UK Ltd
Organon Pharmaceuticals UK Ltd
Day Lewis Medical Ltd
LogixX Pharma Ltd
Lundbeck Limited
Napp Pharmaceuticals Ltd
Bayer Ltd
Morningside Pharmaeuticals
Dexcel Pharma Ltd
CST Pharma Limited
Cipla (EU) Ltd
Relonchem Ltd
RPH Pharmaceuticals AB
Drugsrus Ltd
Ferring Pharmaceuticals Ltd
Milpharm Ltd/aurobinbdo
Crescent Pharma Ltd
Roma Pharmaceuticals Limited
Kyowa Kirin Ltd
Brown and Burk UK Ltd
Lupin Healthcare (UK) Limited
Alliance Pharmaceuticals Limited
Bristol Laboratories Limited
Aristo Pharma Limited
Synchrony
Alissa Healthcare Research Limited
Neon Healthcare Ltd
Aventis Pharma ltd t/a Sanofi
ACIUM LTD
Ascend Laboratories UK Ltd
Rivopharm UK Ltd
Strides Pharma Uk LTD
V Pharma
UpJohn Limited UK
Noumed Life Sciences Limited
Atnahs Pharma UK Ltd
Phoenix Lab
Sciecure Pharma Limited
Intrapharm Laboratories Ltd
Typharm Ltd
Oralieve UK Ltd
FLYNN PHARMA LTD
Takeda UK Ltd
Beaumont Pharma Ltd
Tillomed Laboratories ltd
Focus Pharmaceuticals Ltd
Galen Limited
Clydesdale Pharma ltd
Medley Pharma Ltd
mibe Pharma UK Ltd
Transdermal Limited
Ipca Laboratories UK Ltd
Necessity Supplies Limited
Ferndale Pharmaceuticals Ltd
Merck Sharpe and Dohme (UK) Limited
hameln pharma ltd
Nexcape Pharmaceuticals Ltd.
Fresenius Kabi Limited
Laboratorio Reig Jofre SA
Kent Pharma Ltd
Bowmed Ibisqus Limited
Panpharma UK Limited
Kensington Pharma Ltd
Thea Pharmaceuticals Limited
Stragen UK Ltd
B. Braun Medical Limited
Pierre Fabre Ltd
Macure Pharma ApS
Waverley Pharma Europe Limited
Baxter Healthcare Ltd
Recordati Rare Diseases UK Ltd
Flexipharm Austrading Limited
LEO Pharma
Aguettant Ltd
Torbay Pharmaceuticals
PARI
Seacross Pharmaceuticals Ltd
Altan Pharma Ltd
Lucane Pharma
Norgine Pharmaceuticals Limited
MIP Pharma GmbH
Sobi (Swedish Orphan Biovitrum Ltd)
Tetris Pharma Lts
Sintetica Ltd
Alturix
Euro-Link Pharma Ltd
Vantage Pharmaceuticals Ltd
Chiesi Limited
P M Pharma
Correvio GmbH
Waymade PLC
Recordati Pharmaceuticals Ltd
Northumbria Pharma

Award date

30 December 2021

Contact

Address

2nd Floor, Rutland House, Runcorn, WA7 2ES

Website

https://www.england.nhs.uk/

Contact name

Gemma Tomlinson/Lynne Tierney

[email protected]

Identifiers

Buyer reference

CM/PHG/17/5532

Notice ID

001128-2022

OCID

ocds-h6vhtk-02be28

Explore related tenders

External ID: fts-ocds-h6vhtk-02be28 • Added 20 August 2026